Lubbe Wiesner

5.9k citations

246 papers · 3.6k indexed · h-index 32

Impact in

Infectious Diseases top 0.5%
- Tuberculosis Research and Epidemiology
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Virology top 2%
- HIV Research and Treatment

Papers in

Infectious Diseases 153
- HIV/AIDS drug development and treatment 88
- Tuberculosis Research and Epidemiology 67
- HIV/AIDS Research and Interventions 35
Virology 37
- HIV Research and Treatment 37

Co-authors: Helen McIlleron Paolo Denti Gary Maartens Peter J. Smith Sandra Castel Jennifer Norman Anneke C. Hesseling H. Simon Schaaf
Journals: Antimicrobial Agents and Chemotherapy (42 papers)Journal of Antimicrobial Chemotherapy (19 papers)Clinical Infectious Diseases (10 papers)British Journal of Clinical Pharmacology (10 papers)The International Journal of Tuberculosis and Lung Disease (9 papers)
Partner nations: South Africa United States United Kingdom

In The Last Decade

Lubbe Wiesner

231 papers receiving 3.5k citations

Peers

Countries citing papers authored by Lubbe Wiesner

Since Specialization

Citations

This map shows the geographic impact of Lubbe Wiesner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lubbe Wiesner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lubbe Wiesner more than expected).

Fields of papers citing papers by Lubbe Wiesner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lubbe Wiesner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lubbe Wiesner. The network helps show where Lubbe Wiesner may publish in the future.

Co-authors

The 25 scholars most cited alongside Lubbe Wiesner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lubbe Wiesner Line = papers co-authored together Lubbe Wiesner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Cerebrospinal fluid penetration of cycloserine/terizidone and clofazimine in patients with pulmonary TB Antimicrobial Agents and Chemotherapy ·Caryn M. Upton, José Miguel Calderín Miranda, Andreas H. Diacon, Martin J. Boeree, Paolo Denti, Lubbe Wiesner, Tracy Kellermann, Megan Mcculloch, Rob E. Aarnoutse	2025	0
2	Population pharmacokinetics and dosing of dispersible moxifloxacin formulation in children with rifampicin‐resistant tuberculosis British Journal of Clinical Pharmacology ·Megan Palmer, Yuanxi Zou, Anneke C. Hesseling, Louvina E. van der Laan, Ingrid Courtney, Aarti Kinikar, Naresh Sonkawade, Mandar Paradkar, Vandana Kulkarni, Dessa Jean O. Casalme, M.V.G. Frias, Heather Draper, Lubbe Wiesner, Mats O. Karlsson, Paolo Denti, Elin M. Svensson, Anthony J. Garcia‐Prats	2025	1
3	Determinants of early change in serum creatinine after initiation of dolutegravir‐based antiretroviral therapy in South Africa British Journal of Clinical Pharmacology ·Rephaim Mpofu, Aida N. Kawuma, Roeland E. Wasmann, Godspower Akpomiemie, Nomathemba Chandiwana, Simiso Sokhela, Michelle Moorhouse, François Venter, Paolo Denti, Lubbe Wiesner, Frank A. Post, David W. Haas, Gary Maartens, Phumla Sinxadi	2024	1
4	The impact of alcohol and illicit substance use on the pharmacokinetics of first-line TB drugs Journal of Antimicrobial Chemotherapy ·Marie Wijk, Kamunkhwala Gausi, Samantha Malatesta, Sarah Weber, Richard Court, Bronwyn Myers, Tara Carney, Charles Parry, C. Robert Horsburgh, Laura F. White, Lubbe Wiesner, Robin M. Warren, Caitlin Uren, Helen McIlleron, Frank Kloprogge, Paolo Denti, Karen R. Jacobson	2024	3
5	Population pharmacokinetics of rifabutin among HIV/TB co-infected children on lopinavir/ritonavir-based antiretroviral therapy Antimicrobial Agents and Chemotherapy ·Manna Semere Gebreyesus, Roeland E. Wasmann, Helen McIlleron, Regina Oladokun, Prosper Okonkwo, Lubbe Wiesner, Paolo Denti, Holly Rawizza	2024	0
6	Rifampicin and protein concentrations in paired spinal versus ventricular cerebrospinal fluid samples of children with tuberculous meningitis Journal of Antimicrobial Chemotherapy ·Jill M. Combrinck, Phophi Tshavhungwe, Ursula K. Rohlwink, Nico Enslin, Nqobile Thango, Jed Lazarus, Katie Kriegler, Sandra Castel, Noha Abdelgawad, Helen McIlleron, Paolo Denti, Lubbe Wiesner, Anthony Figaji	2023	1
7	First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial Clinical Infectious Diseases ·Hylke Waalewijn, Alexander J. Szubert, Roeland E. Wasmann, Lubbe Wiesner, Chishala Chabala, Mutsa Bwakura‐Dangarembizi, Shafic Makumbi, Joan Nangiya, Vivian Mumbiro, Veronica Mulenga, Victor Musiime, Lara Monkiewicz, Anna L. Griffiths, Alasdair Bamford, Katja Doerholt, Paolo Denti, David M. Burger, Diana M. Gibb, Helen McIlleron, Angela Colbers, (unknown)	2023	7
8	Optimizing dosing of the cycloserine pro-drug terizidone in children with rifampicin-resistant tuberculosis Antimicrobial Agents and Chemotherapy ·Louvina E. van der Laan, Anthony J. Garcia‐Prats, Helen McIlleron, Mahmoud Tareq Abdelwahab, Jana Winckler, Heather R. Draper, Lubbe Wiesner, H. Simon Schaaf, Anneke C. Hesseling, Paolo Denti	2023	2
9	Pharmacokinetics of standard versus high-dose isoniazid for treatment of multidrug-resistant tuberculosis Journal of Antimicrobial Chemotherapy ·Kamunkhwala Gausi, Maxwell Chirehwa, Elisa H. Ignatius, Richard Court, Xin Sun, Laura Moran, Richard Hafner, Lubbe Wiesner, Susan L. Rosenkranz, Veronique de Jager, Nihal de Vries, Joseph W. Harding, Tawanda Gumbo, Susan Swindells, Andreas H. Diacon, Kelly E. Dooley, Helen McIlleron, Paolo Denti	2022	7
10	Detection of karakin poisoning using a targeted mass spectrometric workflow. SHILAP Revista de lepidopterología ·Daniel J. Watson, Alicia Evans, Marc Blockman, Lubbe Wiesner	2022	0
11	Pharmacokinetics of First-Line Drugs in Children With Tuberculosis, Using World Health Organization–Recommended Weight Band Doses and Formulations Clinical Infectious Diseases ·Chishala Chabala, Anna Turkova, Anneke C. Hesseling, Kevin Zimba, Marieke van der Zalm, Monica Kapasa, Megan Palmer, Maxwell Chirehwa, Lubbe Wiesner, Eric Wobudeya, Aarti Kinikar, Vidya Mave, Syed Hissar, Louise Choo, Kristen LeBeau, Veronica Mulenga, R. A. Aarnoutse, Diana M. Gibb, Helen McIlleron	2021	17
12	De Novo Cobalamin Biosynthesis, Transport, and Assimilation and Cobalamin-Mediated Regulation of Methionine Biosynthesis in Mycobacterium smegmatis Journal of Bacteriology ·Terry Kipkorir, Gabriel T. Mashabela, Timothy J. de Wet, Anastasia Koch, Stephanie S. Dawes, Lubbe Wiesner, Valerie Mizrahi, Digby F. Warner	2021	10
13	Concentration–response relationships of dolutegravir and efavirenz with weight change after starting antiretroviral therapy British Journal of Clinical Pharmacology ·Rulan Griesel, Aida N. Kawuma, Roeland E. Wasmann, Simiso Sokhela, Godspower Akpomiemie, François Venter, Lubbe Wiesner, Paolo Denti, Phumla Sinxadi, Gary Maartens	2021	13
14	Neuropsychiatric toxicity and cycloserine concentrations during treatment for multidrug-resistant tuberculosis International Journal of Infectious Diseases ·Richard Court, Chad M. Centner, Maxwell Chirehwa, Lubbe Wiesner, Paolo Denti, Nihal de Vries, Joseph W. Harding, Tawanda Gumbo, Gary Maartens, Helen McIlleron	2021	31
15	Linezolid Pharmacokinetics in South African Patients with Drug-Resistant Tuberculosis and a High Prevalence of HIV Coinfection Antimicrobial Agents and Chemotherapy ·Sean Wasserman, Paolo Denti, James C. M. Brust, Mahmoud Tareq Abdelwahab, Siphokazi Hlungulu, Lubbe Wiesner, Jennifer Norman, Frederick A. Sirgel, Robin M. Warren, Aliasgar Esmail, Keertan Dheda, Neel R. Gandhi, Graeme Meintjes, Gary Maartens	2019	15
16	Pharmacokinetics, optimal dosing, and safety of linezolid in children with multidrug-resistant tuberculosis: Combined data from two prospective observational studies PLoS Medicine ·Anthony J. Garcia‐Prats, H. Simon Schaaf, Heather R. Draper, Maria Garcia‐Cremades, Jana Winckler, Lubbe Wiesner, Anneke C. Hesseling, Rada Savic	2019	44
17	A Population Pharmacokinetic Analysis Shows that Arylacetamide Deacetylase (AADAC) Gene Polymorphism and HIV Infection Affect the Exposure of Rifapentine Antimicrobial Agents and Chemotherapy ·Jose Francis, Simbarashe Zvada, Paolo Denti, Mark Hatherill, Salome Charalambous, Stanley Mungofa, Rodney Dawson, Susan E. Dorman, Nikhil Gupte, Lubbe Wiesner, Amina Jindani, Thomas S. Harrison, Adeniyi Olagunju, Deirdre Egan, Andrew Owen, Helen McIlleron	2019	20
18	Pharmacokinetics and Drug-Drug Interactions of Lopinavir-Ritonavir Administered with First- and Second-Line Antituberculosis Drugs in HIV-Infected Children Treated for Multidrug-Resistant Tuberculosis Antimicrobial Agents and Chemotherapy ·Louvina E. van der Laan, Anthony J. Garcia‐Prats, H. Simon Schaaf, Tjokosela Tikiso, Lubbe Wiesner, Miné de Kock, Jana Winckler, Jennifer Norman, Helen McIlleron, Paolo Denti, Anneke C. Hesseling	2017	10
19	Levofloxacin Population Pharmacokinetics in South African Children Treated for Multidrug-Resistant Tuberculosis Antimicrobial Agents and Chemotherapy ·Paolo Denti, Anthony J. Garcia‐Prats, Heather R. Draper, Lubbe Wiesner, Jana Winckler, Stephanie Thee, Kelly E. Dooley, Rada Savic, Helen McIlleron, H. Simon Schaaf, Anneke C. Hesseling	2017	38
20	4-Aminoquinoline Antimalarials Containing a Benzylmethylpyridylmethylamine Group Are Active against Drug Resistant Plasmodium falciparum and Exhibit Oral Activity in Mice Journal of Medicinal Chemistry ·Mukesh C. Joshi, John Okombo, Samkele Nsumiwa, Jeffrey Ndove, Dale Taylor, Lubbe Wiesner, Roger Hunter, Kelly Chibale, Timothy J. Egan	2017	19

About Lubbe Wiesner

Lubbe Wiesner is a scholar working on Infectious Diseases, Virology, Pharmacology, Pharmacology and Pediatrics, Perinatology and Child Health, having authored 246 papers that have together received 3.6k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (88 papers), Tuberculosis Research and Epidemiology (67 papers), Pneumocystis jirovecii pneumonia detection and treatment (50 papers), Antibiotics Pharmacokinetics and Efficacy (47 papers), Malaria Research and Control (39 papers), HIV Research and Treatment (37 papers), HIV/AIDS Research and Interventions (35 papers) and Pharmacological Effects and Toxicity Studies (30 papers). The work is most often cited by research in Infectious Diseases (2.0k citations), Virology (354 citations), Pharmacology (282 citations), Epidemiology (1.1k citations) and Pharmacology (511 citations). Lubbe Wiesner has collaborated with scholars based in South Africa, United States and United Kingdom. Frequent co-authors include Helen McIlleron, Paolo Denti, Gary Maartens, Peter J. Smith, Sandra Castel, Jennifer Norman, Anneke C. Hesseling, H. Simon Schaaf, Heather R. Draper and Anthony J. Garcia‐Prats. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy, Clinical Infectious Diseases, British Journal of Clinical Pharmacology and The International Journal of Tuberculosis and Lung Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact